Published in Cancer Weekly, May 10th, 1999
Research has demonstrated that the activation of human MAGE genes leads to the expression of a set of tumor rejection antigens. These antigens are recognized by cytotoxic T lymphocytes (CTLs). As such, C.H. Chen and colleagues from the National Taiwan University Hospital, Taiwan, suggest that these antigens may become the targets of immunotherapy ("High Frequency of Expression of MAGE Genes in Human Hepatocellular Carcinoma," Liver, April 1999;19(2):110-114).
"The expression of MAGE genes was originally found in, but is not restricted, to melanomas," wrote...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.